Tumor marker in primary lung cancer

Journal of UOEH

Volumn 26, Issue 4, 2004, Pages 473-479

  Sugio, Kenji ^a   Sugaya, Masakazu ^a   Hanagiri, Takeshi ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Diagnosis; Lung cancer; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER SCREENING; DIAGNOSTIC TEST; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER;

EID: 10944221773     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.26.473     Document Type: Article

References (10)

1. Gold P & Freedman SO (1965): Demonstration of tumour specific antigen in human colonic carcinoma by immunologic tolerance and absorption technique. J Exp Med 121: 439-462
2. Margolis ML, Hyzy JB, Schenken LL & Schepart BS (1994): Serum tumor markers in non-small cell lung cancer. A comparative analysis. Cancer 73: 605-609
3. Sanchez De Cos J, Masa F, de la Cruz JL, Disdier C & Vergara C (1994): Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 105: 773-776
4. Pujol JL, Grenier J, Daures JP, Daver A, Pujol H & Michel FB (1993): Serum fragment of cytokeratin subunit 19 measured by CYFRA21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53: 61-66
5. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D & Fuhrer P (1979): Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5: 957-971
6. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H & Maeda H (2002): Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 74: 174-179
7. Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M & Itoh T (2004): Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 25: 520-522
8. Pujol JL, Boher JM, Grenier J & Quantin X (2001): CYFRA21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer 31: 221-231
9. Pujol JL, Molinier O, Ebert W et al (2004): CYFRA21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients. Br J Cancer 90: 2097-2105
10. Reinmuth N, Brandt B, Semik M, Kunze WP, Achatzy R, Scheid HH, Broermann P, Berdel WE, Macha HN & Thomas M (2002): Prognostic impact of CYFRA21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 36: 265-270